image credit: Unsplash

Bayer teams with Syntegon to access new continuous manufacturing platform

November 18, 2021

Bayer inked a deal with Syntegon Technology for access to a novel continuous manufacturing process for oral solid dosage forms.

The process uses fluid bed granulation, which yields granules with improved properties, Syntegon said. The company acquired Bosch Packaging Technology and rebranded in 2020. Bayer didn’t release financial terms of the deal.

Syntegon’s continuous manufacturing platform works by dosing, mixing and granulating sub-quantities of the desired product—called X-Keys—that continuously run through the manufacturing chain before being removed. Those X-Keys allow traceability of ingredients, an essential element for pharmaceutical production. Another appeal of the platform is that it doesn’t require technology transfer or scale-up, Syntegon says.

Read More on FiercePharma